Last updated: June 10, 2026
COBENFY suppliers: who manufactures, supplies, and controls COBENFY in-market supply?
Executive summary: COBENFY is not identifiable from authoritative public sources as a licensed, FDA-approved drug brand with a mappable supplier/manufacturer chain based on the information available here. Without an unambiguous drug identity (active ingredient, NDA/BLA/ANDA number, dosage form, and applicant/manufacturer), no defensible supplier list or manufacturing-chain mapping can be produced.
What exactly is COBENFY and who is the approved supplier?
Featured snippet answer: No supplier mapping can be stated for COBENFY because the drug identity is not verifiable here.
What would need to be verified to name suppliers?
- Active ingredient(s) and strength
- FDA application type (NDA vs BLA) and application number
- Dosage form (tablet, injection, etc.)
- Labeling “Manufactured for” / “Distributed by” entities
- Orange Book listing for the relevant NDA (for small molecules) or biologics license holder (for biologics)
What manufacturers supply COBENFY through the FDA labeling chain?
Featured snippet answer: Not determinable without a verified FDA label/application record for COBENFY.
Common supplier chain items to map (but not possible without the label record)
- Drug substance manufacturer (API)
- Drug product manufacturer (DP)
- Site(s) on the FDA label for commercial manufacturing
- Contract manufacturing organizations (CMOs) tied to specific NDCs
- Wholesaler distribution entities and secondary packaging partners
Which contract manufacturing organizations (CMOs) make COBENFY?
Featured snippet answer: Not determinable without a verified CMO disclosure in the labeling or FDA submissions.
Typical places CMOs appear
- “Manufactured by” and address blocks on the FDA label
- Chemistry, Manufacturing, and Controls (CMC) supplements for the NDA/BLA
- Establishment registrations linked to the specific dosage form and site
What is the Orange Book status of COBENFY, and does it list any approved manufacturing sites?
Featured snippet answer: Not determinable without a confirmed Orange Book entry for COBENFY.
What Orange Book would answer for suppliers
- NDA number and applicant holder
- Patent and exclusivity landscape that affects supply timing
- Relevant NDCs tied to the approved manufacturer(s)
Are there generic or biosimilar suppliers for COBENFY, and who is positioned to enter?
Featured snippet answer: Not determinable without a verified reference drug record and approval status.
Entry pathways that would determine competitive suppliers
- ANDA Paragraph IV for small molecules
- 351(k) biosimilar for biologics (if COBENFY is a biologic)
- Authorized generics licensed under settlement or license agreements
What companies have drug supply contracts for COBENFY in the US market?
Featured snippet answer: Not determinable without verified commercial labeling and distribution records for COBENFY.
What would be mapped in a complete supplier dossier
- Label distributor
- Wholesale drug distribution partners
- Direct-to-pharmacy / specialty pharmacy distribution arrangements
- Importers (if any) and foreign-to-US supply routes
How strong is the COBENFY supply chain risk profile by supplier concentration?
Featured snippet answer: Not determinable without the identity of the drug product manufacturing sites and their backup capacity.
What would quantify supply-chain risk
- Number of DP sites per NDC
- API sourcing concentration
- Any known regulatory observations impacting manufacturing continuity
- Back-up CMO manufacturing availability
Key Takeaways
- A supplier list for COBENFY cannot be produced from verified public records with the information provided here.
- Accurate supplier mapping requires a confirmed FDA reference drug identity (NDA/BLA, dosage form, strength, and label record) to trace manufacturing sites, distributors, and NDC-linked suppliers.
- Without that verifiable identity, any named suppliers would be speculative and unusable for R&D, licensing, litigation, or investment decisions.
FAQs
- How do I identify the true manufacturer of a brand drug from the package label?
- Where do US suppliers appear in FDA labeling versus in the Orange Book?
- How do I map NDCs to manufacturing sites for a specific drug product?
- What patents or exclusivity listings affect supplier qualification and generic entry timing?
- How can CMO involvement be confirmed from regulatory or CMC documentation?
References (APA)
No sources are provided because COBENFY cannot be verified to an FDA drug record in the available context, and no authoritative documentation can be cited.
